Emergent Biosolutions Inc
General ticker "EBS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $481.6M
Emergent Biosolutions Inc follows the US Stock Market performance with the rate: 57.5%.
Estimated limits based on current volatility of 3.5%: low 7.93$, high 8.51$
Factors to consider:
- US accounted for 79.4% of revenue in the fiscal year ended 2022-12-31
- Current price 31.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.89$, 6.19$]
- 2024-12-30 to 2025-12-30 estimated range: [3.44$, 9.18$]
Financial Metrics affecting the EBS estimates:
- Negative: Non-GAAP EPS, $ of -6.44 <= 0.10
- Negative: Operating profit margin, % of -40.91 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -63.44 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Investing cash flow per share, $ of 4.15 > -0.12
Short-term EBS quotes
Long-term EBS plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,792.70MM | $1,120.90MM | $1,049.30MM |
| Operating Expenses | $1,440.10MM | $1,286.90MM | $1,775.70MM |
| Operating Income | $352.60MM | $-166.00MM | $-726.40MM |
| Non-Operating Income | $-38.20MM | $-55.70MM | $-4.80MM |
| Interest Expense | $34.50MM | $37.30MM | $87.90MM |
| R&D Expense | $234.00MM | $193.00MM | $111.40MM |
| Income(Loss) | $314.40MM | $-221.70MM | $-731.20MM |
| Taxes | $83.50MM | $2.10MM | $29.30MM |
| Profit(Loss) | $230.90MM | $-223.80MM | $-760.50MM |
| Stockholders Equity | $1,611.50MM | $1,387.70MM | $649.30MM |
| Assets | $2,957.70MM | $3,166.30MM | $1,823.20MM |
| Operating Cash Flow | $321.10MM | $-34.10MM | $-206.30MM |
| Capital expenditure | $225.00MM | $115.80MM | $51.60MM |
| Investing Cash Flow | $-225.00MM | $-381.30MM | $212.30MM |
| Financing Cash Flow | $-141.00MM | $481.20MM | $-535.70MM |
| Earnings Per Share* | $4.10 | $-4.47 | $-14.85 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.